Trial intelligence / Profile preview

Microneedling with fluorouracil in patients with stable vitiligo

IRCT20221105056407N2Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of fluorouracil in Vitiligo, sponsored by Tabriz University of Medical Sciences. Started Mar 2024; status: completed.

02

Drugs

fluorouracil
03

Conditions

Vitiligo

Beyond the preview

Go deeper on IRCT20221105056407N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221105056407N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call